Medivent specialises in the design, manufacture and sale of non-invasive respiratory devices, in particular using a new and patented method of ventilation to achieve what is known as Biphasic Cuirass Ventilation (BCV). We are the world leader in this relatively new and unique method of ventilation.

BCV has been proven to work and be extremely effective for a wide variety of patient groups: neuromuscular, COPD, cystic fibrosis, and ARDS patients amongst many others. There have been over 75 publications supporting this method published to date.